Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Russo, F. Lassandro, E. Carpentieri, G. Rea, A. A. Stanziola, M. Sofia (Naples, Italy). Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission. Eur Respir J 2009; 34: Suppl. 53, 725

Member's Comments

No comment yet.

Related content which might interest you: Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Clinical course and outcome of pulmonary Langerhans‘-cell histiocytosis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Langerhans' cell histiocytosis: clinical and diagnostic features and response to therapy Source: Eur Respir J 2001; 18: Suppl. 33, 219s Year: 2001 Pulmonary Langerhans‘-cell histiocytosis – clinical futures and outcome Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Importance of clinical, radiological and functional methods of investigation for diagnosis and assessment of the efficiency of treatment of Langerhans' cell histiocytosis Source: Eur Respir J 2001; 18: Suppl. 33, 383s Year: 2001 Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Do high resolution CT findings predict lung function impairment in pulmonary Langerhans cell histiocytosis? Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002 Exercise in patients with pulmonary Langerhans cell histiocytosis: performance and mechanisms of limitation Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis? Source: Eur Respir J 2010; 36: 684-686 Year: 2010 Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006